HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range

HORIBA UK Ltd, Medical announces the launch of a D-Dimer parameter for its Yumizen G hemostasis range of instruments.

The new Yumizen GDDi 2 (D-Dimer) reagent kit is now available for HORIBA Medical’s hemostasis instrument range which includes the compact Yumizen G200 coagulation analyzer (pictured).

The new Yumizen GDDi 2 (D-Dimer) reagent kit is now available for HORIBA Medical’s hemostasis instrument range which includes the compact Yumizen G200 coagulation analyzer (pictured).

The new Yumizen G DDi 2 (D-Dimer) reagent kit offers a key measurement and reference exclusion test for the diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It can also be used for monitoring the progress and effectiveness of treatment of Disseminated Intravascular Coagulation (DIC).

HORIBA Medical’s new D-Dimer reagent kit is available for its full range of coagulation instruments which covers the needs of any laboratory. The dedicated hemostasis portfolio includes the fully automatic Yumizen G800, Yumizen G1500, and Yumizen G1550, as well as semi-automatic Yumizen G200 and Yumizen G400 analyzers. Using antibody-coated latex particles and measured via the immuno-turbidimetric channels of these Yumizen G instruments, the new reagent kit delivers D-Dimer results consistency across the range.

The D-Dimer assay when used on very compact coagulation screening platforms such as the Yumizen G400DDi and Yumizen G200, which also have combined immuno-turbidimetric and chromogenic assay capabilities, is particularly ideal for small laboratories, hot labs and as a backup.

On these semi-automatic systems, the Yumizen G DDi 2 reagent kit offers an innovative combination of immuno-turbidimetric test capability and pre-calibrated ready-to-use reagent.

Offering a cost-efficient solution, the new assay minimizes preparation time due to its ready-to-use liquid format. Furthermore, as the reagent is pre-calibrated it removes the need for a costly and time-consuming calibration step. Its high stability and optimized volume packaging also avoids wastage.

HORIBA Medical’s new D-Dimer test kit is fully compliant with Gold Standard performances, having a Negative Predictive Value of 99% and an absence of hook effect up to 25 µg FEU/ml. It also offers slope check and post dilution function on both fully automatic and semi-automatic systems with a cut-off value at 0.5 µg FEU/ml.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    HORIBA Medical. (2019, June 20). HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range. News-Medical. Retrieved on April 17, 2024 from https://www.news-medical.net/news/20190325/HORIBA-Medical-introduces-D-Dimer-reagent-for-Yumizen-G-hemostasis-range.aspx.

  • MLA

    HORIBA Medical. "HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range". News-Medical. 17 April 2024. <https://www.news-medical.net/news/20190325/HORIBA-Medical-introduces-D-Dimer-reagent-for-Yumizen-G-hemostasis-range.aspx>.

  • Chicago

    HORIBA Medical. "HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range". News-Medical. https://www.news-medical.net/news/20190325/HORIBA-Medical-introduces-D-Dimer-reagent-for-Yumizen-G-hemostasis-range.aspx. (accessed April 17, 2024).

  • Harvard

    HORIBA Medical. 2019. HORIBA Medical introduces D-Dimer reagent for Yumizen G hemostasis range. News-Medical, viewed 17 April 2024, https://www.news-medical.net/news/20190325/HORIBA-Medical-introduces-D-Dimer-reagent-for-Yumizen-G-hemostasis-range.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HORIBA Medical and CellaVision collaborate on new automated Digital Cell Morphology solution to enhance lab workflows